The scientists of the Central Drug Research Institute of India (CDRI), Lucknow, conducted clinical tests on Memory Plus, a drug which owes its origin to the traditional herb 'Brahmi'. The tests established its efficacy in children suffering from attention deficit hyperactivity disorder (ADHD), a condition in which children are hyperactive and lack the will or the power to concentrate. Trials were conducted in the department of paediatrics, BRD Medical College, Gorakhpur by administering Memory Plus and placebos (inert substances) on children in the age group of 8-10 years for a period of 12 months.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
.png)
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.